Supercooling May Aid Drug Delivery
News May 08, 2015
Water, when cooled below 32 F, eventually freezes — its science known even to preschoolers. But some substances, when they undergo a process called "rapid-freezing" or "supercooling," remain in liquid form — even at below-freezing temperatures.
The supercooling phenomenon has been studied for its possible applications in a wide spectrum of fields. According to this new research, membranes can be engineered to crystallize at a specific time. In other words, it is indeed possible to control what was once considered a wild and unpredictable process — and it may revolutionize the delivery of drugs in the human body, providing a way to "freeze" the drugs at an optimal time and location in the body.
The study was led jointly by Roy Beck of the Department of Physics at TAU's School of Physics and Astronomy and Prof. Dan Peer of the Department of Cell Research and Immunology at TAU's Faculty of Life Sciences, and conducted by TAU graduate students Guy Jacoby, Keren Cohen and Kobi Barkai.
"We describe a supercooled material as 'metastable,' meaning it is very sensitive to any external perturbation that may transform it back to its stable low-temperature state," Beck said. "We discovered in our study that it is possible to control the process and harness the advantages of the fluid/not-fluid transition to design a precise and effective nanoscale drug encapsulating system."
For the purpose of the study, the researchers conducted experiments on nanoscale drug vesicles (fluid-filled sacs that deliver drugs to their targets) to determine the precise dynamics of crystallization. The researchers used a state-of-the-art X-ray scattering system sensitive to nanoscale structures.
"One key challenge in designing new nanovesicles for drug delivery is their stability," said Beck. "On the one hand, you need a stable vesicle that will entrap your drug until it reaches the specific diseased cell. But on the other, if the vesicle is too stable, the payload may not be released upon arrival at its target."
"Supercooled material is a suitable candidate since the transition between liquid and crystal states is very drastic and the liquid membrane explodes to rearrange as crystals. Therefore this new physical insight can be used to release entrapped drugs at the target and not elsewhere in the body's microenvironment. This is a novel mechanism for timely drug release."
The researchers found that the membranes were able to remain stable for tens of hours before collectively crystallizing at a predetermined time.
"What was amazing was our ability to reproduce the results over and over again without any complicated techniques," said Beck. "We showed that the delayed crystallization was not sensitive to minor imperfection or external perturbation. Moreover, we found multiple alternative ways to 'tweak the clock' and start the crystallization process."
The researchers are investigating an appropriate new nanocapsule capable of releasing medication at a specific time and place in the body. "The challenge now is to find the right drugs to exploit our insights for the medical benefit of patients," said Beck.
A new experimental system has been designed that can rapidly assess the pathogenic effects of a drug on a baby's developing brain. The system uses embryonic stem cells reprogrammed into neurons, and offers a powerful tool for probing genetic and molecular underpinnings of drug-induced neurodevelopmental disorders.READ MORE
An investigational drug for the treatment of sickle cell disease shows early promise in Phase 2a clinical trial. The orally administered drug, given to adult patients with sickle cell disease, is demonstrating tolerability and the ability to impact both red and white blood cell biomarkers of the disease.READ MORE